- Home
- NAPA vs IART Comparison
NAPA vs IART Comparison
Compare NAPA & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAPA
- IART
- Stock Information
- Founded
- NAPA 1976
- IART 1989
- Country
- NAPA United States
- IART United States
- Employees
- NAPA N/A
- IART N/A
- Industry
- NAPA Beverages (Production/Distribution)
- IART Medical/Dental Instruments
- Sector
- NAPA Consumer Staples
- IART Health Care
- Exchange
- NAPA Nasdaq
- IART Nasdaq
- Market Cap
- NAPA 1.6B
- IART 1.8B
- IPO Year
- NAPA 2021
- IART 1995
- Fundamental
- Price
- NAPA $11.08
- IART $23.00
- Analyst Decision
- NAPA Hold
- IART Hold
- Analyst Count
- NAPA 8
- IART 8
- Target Price
- NAPA $10.51
- IART $28.14
- AVG Volume (30 Days)
- NAPA 1.5M
- IART 632.1K
- Earning Date
- NAPA 12-05-2024
- IART 11-04-2024
- Dividend Yield
- NAPA N/A
- IART N/A
- EPS Growth
- NAPA N/A
- IART N/A
- EPS
- NAPA 0.39
- IART N/A
- Revenue
- NAPA $425,914,000.00
- IART $1,564,920,000.00
- Revenue This Year
- NAPA $22.74
- IART $6.71
- Revenue Next Year
- NAPA $6.79
- IART $6.08
- P/E Ratio
- NAPA $28.19
- IART N/A
- Revenue Growth
- NAPA 7.19
- IART 1.45
- 52 Week Low
- NAPA $5.38
- IART $16.81
- 52 Week High
- NAPA $11.10
- IART $45.42
- Technical
- Relative Strength Index (RSI)
- NAPA 75.95
- IART 47.04
- Support Level
- NAPA $10.96
- IART $22.87
- Resistance Level
- NAPA $11.09
- IART $24.59
- Average True Range (ATR)
- NAPA 0.02
- IART 0.70
- MACD
- NAPA -0.04
- IART -0.25
- Stochastic Oscillator
- NAPA 83.33
- IART 13.74
About NAPA The Duckhorn Portfolio Inc.
The Duckhorn Portfolio Inc produces luxury and ultra-luxury wine across a portfolio of winery brands, including Duckhorn Vineyards, Paraduxx, Goldeneye, Migration, Decoy, Canvasback, Calera, Kosta Browne, Greenwing and Postmark. Its revenue is comprised of wholesale and direct-to-consumer sales. Wholesale revenue is generated through sales directly to California retailers and restaurants, sales to distributors and agents located in other states throughout the United States, and sales to export distributors that sell internationally.
About IART Integra LifeSciences Holdings Corporation
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.